|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-12-19
|
|
pubmed:abstractText |
Dyslipidemia is a common complication of chronic kidney disease. Lipoprotein lipase (LPL) 1595 C/G and hepatic lipase (HL) -480 C/T single nucleotide polymorphisms (SNPs) influence lipid profile and predisposition for cardiovascular disease in the general population. The present study was undertaken to clarify the impact of the two polymorphisms on lipid parameters and cardiovascular risk in incident dialysis patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9735
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
555-60
|
|
pubmed:meshHeading |
pubmed-meshheading:19052449-Cholesterol, HDL,
pubmed-meshheading:19052449-Chronic Disease,
pubmed-meshheading:19052449-Humans,
pubmed-meshheading:19052449-Kidney Diseases,
pubmed-meshheading:19052449-Lipase,
pubmed-meshheading:19052449-Lipids,
pubmed-meshheading:19052449-Lipoprotein Lipase,
pubmed-meshheading:19052449-Polymorphism, Genetic,
pubmed-meshheading:19052449-Renal Dialysis,
pubmed-meshheading:19052449-Survival Rate,
pubmed-meshheading:19052449-Triglycerides
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.
|
|
pubmed:affiliation |
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden. chmiel@amg.gda.pl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
